Výsledky vyhledávání - "Cellular Reprogramming Techniques methods"
-
1
Autoři: a další
Přispěvatelé: a další
Témata: Epigenetics, Epigenetic Memory, Epigenetic Repression, Metabolic Reprogramming/drug effects, Cellular Reprogramming/drug effects, Cellular Reprogramming/genetics, Cellular Reprogramming Techniques/methods, Metabolic Reprogramming, Metabolic Reprogramming/genetics, Triple-Negative Breast Cancer, Breast cancer, Signal processing, Signal Transduction, Signal Transduction/genetics, cancer stem cells, metastatic, tumor reduction
Relation: https://zenodo.org/records/15278175; oai:zenodo.org:15278175; https://doi.org/10.5281/zenodo.15278175
-
2
Autoři: a další
Přispěvatelé: a další
Témata: Epigenetics, Epigenetic Memory, Epigenetic Repression, Metabolic Reprogramming/drug effects, Cellular Reprogramming/drug effects, Cellular Reprogramming/genetics, Cellular Reprogramming Techniques/methods, Metabolic Reprogramming, Metabolic Reprogramming/genetics, Triple-Negative Breast Cancer, Breast cancer, Signal processing, Signal Transduction, Signal Transduction/genetics
Relation: https://zenodo.org/records/15277781; oai:zenodo.org:15277781; https://doi.org/10.5281/zenodo.15277781
-
3
Autoři: a další
Zdroj: http://lobid.org/resources/99370675582406441#!, 13(1):28.
Témata: Embryonic Germ Cells/metabolism [MeSH], Animal Experimentation [MeSH], Disease Progression [MeSH], Fibrosis/pathology [MeSH], Risk Factors [MeSH], Gene Ontology [MeSH], 850 k EPIC array, Genome-Wide Association Study/methods [MeSH], Male [MeSH], DNA methylation, Primary Myelofibrosis/genetics [MeSH], DNA Fingerprinting/methods [MeSH], Fusion Proteins, bcr-abl/genetics [MeSH], Female [MeSH], Humans [MeSH], Bone Marrow/metabolism [MeSH], Predictive Value of Tests [MeSH], Prefibrotic PMF, Cellular Reprogramming Techniques/methods [MeSH], Epigenomics/methods [MeSH], Fibrosis/genetics [MeSH], Cell Competition/genetics [MeSH], CpG Islands/genetics [MeSH], Cancer epigenetics and diagnostics, DNA Methylation [MeSH], Research, Prognosis [MeSH], Primary Myelofibrosis/pathology [MeSH], Myelofibrosis
Relation: https://repository.publisso.de/resource/frl:6463989; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860011/
-
4
Autoři: a další
Přispěvatelé: a další
Zdroj: Circulation Research. 120:848-861
Témata: Male, 0301 basic medicine, Hindlimb/physiology, Cells, Nude, Transcription Factors/genetics, regenerative medicine, Mice, Nude, Neovascularization, Physiologic, ischemia, Mice, 03 medical and health sciences, Ischemia, fibroblasts, Human Umbilical Vein Endothelial Cells, Cell Differentiation/physiology, Animals, Humans, Cellular Reprogramming Techniques, Neovascularization, Cells, Cultured, Cultured, Endothelial Cells, Cell Differentiation, Fibroblasts, Transcription Factors/biosynthesis, Ischemia/metabolism, endothelial cells, Cellular Reprogramming Techniques/methods, Hindlimb/blood supply, Hindlimb, 3. Good health, Endothelial Cells/physiology, Physiologic/physiology, cell therapy, Fibroblasts/physiology, Transcription Factors
Přístupová URL adresa: https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.116.309833
https://pubmed.ncbi.nlm.nih.gov/28003219
https://open.library.emory.edu/publications/emory:s8k5s/
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.116.309833
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336520
https://pubmed.ncbi.nlm.nih.gov/28003219/
http://europepmc.org/articles/PMC5336520
https://yonsei.pure.elsevier.com/en/publications/direct-reprogramming -of-human-dermal-fibroblasts-into-endothelial -
5
Autoři: a další
Témata: Antineoplastic Agents, Immunological/pharmacology, Cellular Reprogramming Techniques/methods, Combined Modality Therapy, Humans, Immune Checkpoint Inhibitors/pharmacology, Immunotherapy/methods, Immunotherapy/trends, Neoplasms/drug therapy, Neoplasms/genetics, Neoplasms/immunology, Tumor Microenvironment/drug effects, Tumor Microenvironment/immunology, Cold tumors, Hot tumors, Immunotherapy, Inflamed tumors, Tumor microenvironment
Relation: Cancer Treatment Reviews; https://iris.unil.ch/handle/iris/38788; serval:BIB_4AB33FCA1873; 000708666700001
Nájsť tento článok vo Web of Science
Full Text Finder